Bio interaction News
-
Is evolving APAC healthcare ecosystem addressing current regulatory bottlenecks?
Bio interaction | Regulatory | By Hithaishi C Bhaksar | 4 Comment | 01 Jul, 2022
With the innovation boom in Asia and many early-stage assets emerging, the time is ripe for Asian economies to establish...Read more
-
“It is Abcam's goal to fuel R&D in the APAC region”
Bio interaction | Opinion | By Dr Manbeena Chawla | 4 Comment | 09 Jun, 2022
What are the major plans in store for the new APAC hub at Singapore? For a company like Abcam which strongly believes t...Read more
-
Leveraging Academia-Industry Collabs to Scale-up S&T Innovations
Bio interaction | Opinion | By Hithaishi C Bhaskar | 2 Comment | 28 Apr, 2022
Global challenges are too large to tackle in isolation. The creation of new shared value in public research through acad...Read more
-
How far does cloud technology ensure drug safety and operational efficiencies at pharmacovigilance?
Bio interaction | Opinion | By Hithaishi C Bhaskar | 2 Comment | 12 Apr, 2022
From popular over-the-counter medications like paracetamol to more complicated drugs and vaccines, pharmacovigilance pla...Read more
-
Ensuring compliance with data governance regulations in the Healthcare Machine learning (ML) space
Bio interaction | Opinion | By Hithaishi C Bhaskar | 5 Comment | 06 Apr, 2022
The healthcare industry is becoming increasingly information-driven. Smart machines are creating a positive impact to en...Read more
-
Healthcare in the post-COVID era: accessible, rapid and tech-driven
Bio interaction | Opinion | 5 Comment | 07 Mar, 2022
The permanent shift in consumer preferences, rising expectations for enhanced customer experiences (CX) and digital tran...Read more
-
Accelerating healthcare innovation in a post-pandemic world
Bio interaction | Opinion | By Hithaishi C Bhaksar | 2 Comment | 07 Mar, 2022
It's estimated that one in three people in developing countries can't get essential medicines on a regular basis. Even i...Read more
-
Bio interaction | Opinion | By Hithaishi C Bhaskar | 2 Comment | 04 Feb, 2022
Can automation and AI leverage an effective Pharmacovigilance by tackling the consequences of adverse events (AEs)? Wh...Read more
-
“Enhanced traceability plays a crucial role in building a resilient biopharma supply chain”
Bio interaction | Opinion | By Hithaishi C Bhaskar | 2 Comment | 04 Feb, 2022
How do you foresee digitalisation trends in APAC pharmaceutical supply chain improvising visibility, agility, and busi...Read more
